MarketCap
Facebook
X
Telegram
Country |
 Canada |
IPO year |
- |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ CAPITAL |
Shares |
3.17 M |
Market Cap[1] |
$ 314 M |
EBITDA (LTM) |
$ -19 M |
P/E (LTM) |
- |
P/S (LTM) |
23.714579 |
EPS (LTM) |
-5.85 |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Humanigen
HGEN
|
- | -81.12 % | $ 4.28 M | Nasdaq Global Select Market |  USA |
 |
Sorrento Therapeutics
SRNE
|
- | -29.58 % | $ 126 M | Nasdaq Global Select Market | USA |
 |
Surface Oncology
SURF
|
- | - | $ 59.7 M | Nasdaq Global Select Market | USA |
 |
Sierra Oncology
SRRA
|
- | -0.05 % | $ 1.34 B | Nasdaq Global Select Market | Canada |
 |
Cocrystal Pharma
COCP
|
$ 1.03 | -6.33 % | $ 11.6 M | Nasdaq Capital Market | USA |
 |
Atea Pharmaceuticals
AVIR
|
$ 4.24 | -3.97 % | $ 346 M | Nasdaq Global Select Market | USA |
 |
Nektar Therapeutics
NKTR
|
$ 37.82 | -0.01 % | $ 638 M | Nasdaq Global Select Market,SPB | USA |
 |
Vaccinex
VCNX
|
- | -61.37 % | $ 654 K | Nasdaq Global Select Market | USA |
 |
Nymox Pharmaceutical Corporation
NYMX
|
- | -19.68 % | $ 18.4 M | Nasdaq Capital Market | Canada |
 |
Akero Therapeutics
AKRO
|
- | - | $ 3.67 B | Nasdaq Global Select Market,SPB | USA |
 |
Lineage Cell Therapeutics
LCTX
|
$ 1.05 | -3.24 % | $ 242 M | NYSE American | USA |
 |
Jounce Therapeutics
JNCE
|
- | - | $ 98.4 M | Nasdaq Global Select Market | USA |
 |
Verona Pharma plc
VRNA
|
- | - | $ 69.7 B | Nasdaq Global Select Market |  Britain |
 |
Corner Growth Acquisition Corp.
COOL
|
- | -0.89 % | $ 114 M | Nasdaq Global Select Market | USA |
 |
Acorda Therapeutics
ACOR
|
- | -24.86 % | $ 820 K | Nasdaq Global Select Market | USA |
 |
Ampio Pharmaceuticals
AMPE
|
- | -11.43 % | $ 502 K | NYSE American | USA |
 |
Akari Therapeutics, Plc
AKTX
|
$ 7.0 | -8.62 % | $ 471 B | Nasdaq Capital Market | Britain |
 |
Mersana Therapeutics
MRSN
|
- | - | $ 3.56 B | Nasdaq Global Select Market | USA |
 |
CymaBay Therapeutics
CBAY
|
- | - | $ 3.45 B | Nasdaq Global Select Market | USA |
 |
Freeline Therapeutics Holdings plc
FRLN
|
- | - | $ 384 M | Nasdaq Global Select Market | Britain |
 |
Genmab A/S
GMAB
|
$ 54.08 | -3.08 % | $ 3.5 B | Nasdaq Global Select Market |  Danmark |
 |
Allakos
ALLK
|
- | - | $ 28.6 M | Nasdaq Global Select Market,SPB | USA |
 |
Timber Pharmaceuticals
TMBR
|
- | - | $ 717 K | NYSE American | USA |
 |
Immuron Limited
IMRN
|
$ 0.9 | 2.27 % | $ 208 M | Nasdaq Global Select Market |  Australia |
 |
G1 Therapeutics
GTHX
|
- | - | $ 370 M | Nasdaq Global Select Market,SPB | USA |
 |
Amryt Pharma plc
AMYT
|
- | - | $ 621 M | Nasdaq Global Select Market | Britain |
 |
BioVie
BIVI
|
$ 1.25 | -3.85 % | $ 9.06 M | Nasdaq Capital Market | USA |
 |
Kinnate Biopharma
KNTE
|
- | - | $ 123 M | Nasdaq Global Select Market | USA |
 |
Mustang Bio
MBIO
|
$ 0.44 | 12.95 % | $ 2.16 M | Nasdaq Global Market | USA |
|
Cerevel Therapeutics Holdings
CERE
|
- | - | $ 7.29 B | Nasdaq Capital Market | USA |
 |
NexImmune
NEXI
|
- | 70.13 % | $ 4.12 M | Nasdaq Global Market | USA |
 |
Codexis
CDXS
|
$ 1.0 | -9.91 % | $ 87.1 M | Nasdaq Global Select Market | USA |
 |
Theravance Biopharma
TBPH
|
$ 17.03 | 0.03 % | $ 857 M | Nasdaq Global Select Market |  Cayman-islands |
 |
Compugen Ltd.
CGEN
|
$ 2.06 | -3.72 % | $ 192 M | Nasdaq Global Market,SPB |  Israel |
 |
IMV
IMV
|
- | - | $ 13.1 M | Nasdaq Global Select Market | Canada |
 |
Sanofi
SNY
|
$ 48.23 | 0.22 % | $ 58.9 B | Nasdaq Global Select Market |  France |
 |
Karuna Therapeutics
KRTX
|
- | - | $ 12.2 B | Nasdaq Global Market,SPB | USA |
 |
Chimerix
CMRX
|
- | - | $ 756 M | Nasdaq Global Select Market | USA |
 |
Atreca
BCEL
|
- | -11.76 % | $ 5.79 M | Nasdaq Global Select Market | USA |
 |
LogicBio Therapeutics
LOGC
|
- | - | $ 229 M | Nasdaq Global Market | USA |
 |
RedHill Biopharma Ltd.
RDHL
|
$ 0.38 | -5.06 % | $ 4.68 B | Nasdaq Global Market | Israel |
|
89bio
ETNB
|
- | - | $ 1.55 B | Nasdaq Global Market | USA |
 |
Fusion Pharmaceuticals
FUSN
|
- | - | $ 1.41 B | Nasdaq Global Select Market | Canada |
 |
Gritstone Oncology
GRTS
|
- | 0.42 % | $ 213 M | Nasdaq Global Select Market | USA |
 |
Harpoon Therapeutics
HARP
|
- | - | $ 763 M | Nasdaq Global Select Market | USA |
 |
HOOKIPA Pharma
HOOK
|
- | -6.92 % | $ 79.4 M | Nasdaq Global Select Market | USA |
 |
Guardion Health Sciences
GHSI
|
- | -0.31 % | $ 3.64 M | Nasdaq Capital Market | USA |
 |
Opiant Pharmaceuticals
OPNT
|
- | - | $ 109 M | Nasdaq Global Select Market | USA |
 |
Akouos
AKUS
|
- | 0.23 % | $ 488 M | Nasdaq Global Select Market | USA |
 |
Otonomy
OTIC
|
- | -1.96 % | $ 4.68 M | Nasdaq Global Select Market | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.